
Angela A. Armstrong
Examiner (ID: 7226, Phone: (571)272-7598 , Office: P/2659 )
| Most Active Art Unit | 2659 |
| Art Unit(s) | 2659, 2641, 2741, 2654, 2626 |
| Total Applications | 1003 |
| Issued Applications | 675 |
| Pending Applications | 123 |
| Abandoned Applications | 230 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8549284
[patent_doc_number] => 08324165
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-04
[patent_title] => 'Compositions for treating arthritis comprising HG1023575 polypeptide'
[patent_app_type] => utility
[patent_app_number] => 12/992582
[patent_app_country] => US
[patent_app_date] => 2009-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 26727
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12992582
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/992582 | Compositions for treating arthritis comprising HG1023575 polypeptide | May 12, 2009 | Issued |
Array
(
[id] => 6102573
[patent_doc_number] => 20110166066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-07
[patent_title] => 'CATESTATIN (CST) AND ITS VARIANTS FOR TREATMENT OF CARDIOVASCULAR AND METABOLIC DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/736842
[patent_app_country] => US
[patent_app_date] => 2009-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 14244
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20110166066.pdf
[firstpage_image] =>[orig_patent_app_number] => 12736842
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/736842 | CATESTATIN (CST) AND ITS VARIANTS FOR TREATMENT OF CARDIOVASCULAR AND METABOLIC DISORDERS | May 7, 2009 | Abandoned |
Array
(
[id] => 5490820
[patent_doc_number] => 20090291891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-26
[patent_title] => 'VEGF variant that lacks VEGFR-1 binding activity and its use in promotion of re-endothelization and prevention of in-stent restenosis'
[patent_app_type] => utility
[patent_app_number] => 12/385365
[patent_app_country] => US
[patent_app_date] => 2009-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10319
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0291/20090291891.pdf
[firstpage_image] =>[orig_patent_app_number] => 12385365
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/385365 | VEGF variant that lacks VEGFR-1 binding activity and its use in promotion of re-endothelization and prevention of in-stent restenosis | Apr 5, 2009 | Abandoned |
Array
(
[id] => 6631226
[patent_doc_number] => 20100035299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-11
[patent_title] => 'METHODS FOR THE PURIFICATION OF POLYPEPTIDE CONJUGATES'
[patent_app_type] => utility
[patent_app_number] => 12/418530
[patent_app_country] => US
[patent_app_date] => 2009-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 38837
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20100035299.pdf
[firstpage_image] =>[orig_patent_app_number] => 12418530
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/418530 | METHODS FOR THE PURIFICATION OF POLYPEPTIDE CONJUGATES | Apr 2, 2009 | Abandoned |
Array
(
[id] => 8571471
[patent_doc_number] => 08338115
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-25
[patent_title] => 'Assays for detecting T2R76 taste modulatory compounds'
[patent_app_type] => utility
[patent_app_number] => 12/413102
[patent_app_country] => US
[patent_app_date] => 2009-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20006
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12413102
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/413102 | Assays for detecting T2R76 taste modulatory compounds | Mar 26, 2009 | Issued |
Array
(
[id] => 6148744
[patent_doc_number] => 20110020339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'METHODS OF TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 12/935038
[patent_app_country] => US
[patent_app_date] => 2009-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8288
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20110020339.pdf
[firstpage_image] =>[orig_patent_app_number] => 12935038
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/935038 | Methods of treatment of eosinophilic bronchitis with an anti-IL-5 antibody | Mar 26, 2009 | Issued |
Array
(
[id] => 7656440
[patent_doc_number] => 20110305709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-15
[patent_title] => 'CALCIUM SENSOR STIM1 AND THE PLATELET SOC CHANNEL ORAI1 (CRACM1) ARE ESSENTIAL FOR PATHOLOGICAL THROMBUS FORMATION'
[patent_app_type] => utility
[patent_app_number] => 12/933191
[patent_app_country] => US
[patent_app_date] => 2009-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17229
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0305/20110305709.pdf
[firstpage_image] =>[orig_patent_app_number] => 12933191
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/933191 | CALCIUM SENSOR STIM1 AND THE PLATELET SOC CHANNEL ORAI1 (CRACM1) ARE ESSENTIAL FOR PATHOLOGICAL THROMBUS FORMATION | Mar 19, 2009 | Abandoned |
Array
(
[id] => 6149234
[patent_doc_number] => 20110020829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'RAPID ASSAY FOR DETECTING ATAXIA-TELANGIECTASIA HOMOZYGOTES AND HETEROZYGOTES'
[patent_app_type] => utility
[patent_app_number] => 12/921758
[patent_app_country] => US
[patent_app_date] => 2009-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8304
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20110020829.pdf
[firstpage_image] =>[orig_patent_app_number] => 12921758
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/921758 | RAPID ASSAY FOR DETECTING ATAXIA-TELANGIECTASIA HOMOZYGOTES AND HETEROZYGOTES | Mar 12, 2009 | Abandoned |
Array
(
[id] => 5398288
[patent_doc_number] => 20090318351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'METHOD OF TREATING ACUTE ST-ELEVATION MYOCARDIAL INFARCTION WITH A DELTA PKC ANTAGONIST'
[patent_app_type] => utility
[patent_app_number] => 12/403302
[patent_app_country] => US
[patent_app_date] => 2009-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 12450
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20090318351.pdf
[firstpage_image] =>[orig_patent_app_number] => 12403302
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/403302 | METHOD OF TREATING ACUTE ST-ELEVATION MYOCARDIAL INFARCTION WITH A DELTA PKC ANTAGONIST | Mar 11, 2009 | Abandoned |
Array
(
[id] => 5958429
[patent_doc_number] => 20110182816
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-28
[patent_title] => 'ANTIBODY AGAINST OXIDIZED LDL/ß2GPI COMPLEX AND USE OF THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/000319
[patent_app_country] => US
[patent_app_date] => 2009-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15181
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20110182816.pdf
[firstpage_image] =>[orig_patent_app_number] => 13000319
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/000319 | Antibody against oxidized LDL/β2GPI complex and use of the same | Mar 8, 2009 | Issued |
Array
(
[id] => 5958430
[patent_doc_number] => 20110182817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-28
[patent_title] => 'ANTIBODY AGAINST CALCIFIED GLOBULE AND USE OF THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/000325
[patent_app_country] => US
[patent_app_date] => 2009-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 27385
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20110182817.pdf
[firstpage_image] =>[orig_patent_app_number] => 13000325
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/000325 | Antibody against calcified globule and use of the same | Mar 8, 2009 | Issued |
Array
(
[id] => 6142178
[patent_doc_number] => 20110129468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-02
[patent_title] => 'PURIFIED IMMUNOGLOBULIN FUSION PROTEINS AND METHODS OF THEIR PURIFICATION'
[patent_app_type] => utility
[patent_app_number] => 12/919869
[patent_app_country] => US
[patent_app_date] => 2009-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 27513
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20110129468.pdf
[firstpage_image] =>[orig_patent_app_number] => 12919869
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/919869 | PURIFIED IMMUNOGLOBULIN FUSION PROTEINS AND METHODS OF THEIR PURIFICATION | Feb 26, 2009 | Abandoned |
Array
(
[id] => 5436484
[patent_doc_number] => 20090171071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-02
[patent_title] => 'PYY Agonists and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/393259
[patent_app_country] => US
[patent_app_date] => 2009-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 23633
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20090171071.pdf
[firstpage_image] =>[orig_patent_app_number] => 12393259
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/393259 | PYY Agonists and Uses Thereof | Feb 25, 2009 | Abandoned |
Array
(
[id] => 9389132
[patent_doc_number] => 08685728
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-01
[patent_title] => 'Kit containing stem cells and cytokines for use in attenuating immune responses'
[patent_app_type] => utility
[patent_app_number] => 12/362847
[patent_app_country] => US
[patent_app_date] => 2009-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 10573
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12362847
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/362847 | Kit containing stem cells and cytokines for use in attenuating immune responses | Jan 29, 2009 | Issued |
Array
(
[id] => 5458678
[patent_doc_number] => 20090258830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => 'DIAGNOSTIC AND THERAPEUTIC USES OF GELSOLIN IN RENAL FAILURE'
[patent_app_type] => utility
[patent_app_number] => 12/358868
[patent_app_country] => US
[patent_app_date] => 2009-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 19372
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20090258830.pdf
[firstpage_image] =>[orig_patent_app_number] => 12358868
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/358868 | Diagnostic and therapeutic uses of gelsolin in renal failure | Jan 22, 2009 | Issued |
Array
(
[id] => 8555389
[patent_doc_number] => 08329861
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-11
[patent_title] => 'Protein KTPAF50'
[patent_app_type] => utility
[patent_app_number] => 12/810331
[patent_app_country] => US
[patent_app_date] => 2008-12-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 5343
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12810331
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/810331 | Protein KTPAF50 | Dec 24, 2008 | Issued |
Array
(
[id] => 5434958
[patent_doc_number] => 20090169544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-02
[patent_title] => 'FORMULATION'
[patent_app_type] => utility
[patent_app_number] => 12/343787
[patent_app_country] => US
[patent_app_date] => 2008-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8994
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20090169544.pdf
[firstpage_image] =>[orig_patent_app_number] => 12343787
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/343787 | FORMULATION | Dec 23, 2008 | Abandoned |
Array
(
[id] => 6025804
[patent_doc_number] => 20110053852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'USE OF PODOCAN PROTEIN IN TREATING CARDIOVASCULAR DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/809899
[patent_app_country] => US
[patent_app_date] => 2008-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 26528
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20110053852.pdf
[firstpage_image] =>[orig_patent_app_number] => 12809899
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/809899 | USE OF PODOCAN PROTEIN IN TREATING CARDIOVASCULAR DISEASES | Dec 18, 2008 | Abandoned |
Array
(
[id] => 6001644
[patent_doc_number] => 20110117550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-19
[patent_title] => 'METHOD OF DETERMINING ANTI-HYPERTENSIVE DRUG THERAPY BY GENETIC PROFILING'
[patent_app_type] => utility
[patent_app_number] => 12/808483
[patent_app_country] => US
[patent_app_date] => 2008-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9140
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20110117550.pdf
[firstpage_image] =>[orig_patent_app_number] => 12808483
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/808483 | METHOD OF DETERMINING ANTI-HYPERTENSIVE DRUG THERAPY BY GENETIC PROFILING | Dec 17, 2008 | Abandoned |
Array
(
[id] => 5457842
[patent_doc_number] => 20090257994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => 'Chimeric immunoreceptor useful in treating human cancers'
[patent_app_type] => utility
[patent_app_number] => 12/314195
[patent_app_country] => US
[patent_app_date] => 2008-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 13328
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20090257994.pdf
[firstpage_image] =>[orig_patent_app_number] => 12314195
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/314195 | Chimeric immunoreceptor useful in treating human cancers | Dec 4, 2008 | Abandoned |